Skip to main content

MARSHALL WACE, LLP

Position in NBIX — Neurocrine Biosciences Inc

CIK 1318757 LONDON, X0

Position in NBIX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$45,632,878
-$21,419,750 QoQ
Shares Held
270,754
-46.8% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#65
of 768 holders
Holding Since
Sep 2020
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (7.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NBIX
Neurocrine Biosciences Inc
This page
270,754 $45,632,878

All Filings in NBIX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $45,632,878 270,754
2026-03-31 $67,052,628 508,977
2025-12-31 $49,476,401 348,843
2025-09-30 $13,657,429 97,289
2025-06-30 $5,234,861 41,649
2024-12-31 $331,012 2,425
2024-03-31 $4,548,049 32,976
2023-03-31 $16,466,773 162,683
2022-12-31 $3,636,470 30,446
2021-12-31 $898,799 10,553
2020-12-31 $7,576,367 79,044
2020-09-30 $14,130,038 146,943